On staff since November 2015
Navin Pinto, MD is an attending physician at Seattle Children's Hospital and an Associate Professor of Pediatrics at the University of Washington School of Medicine. Dr. Pinto is the Outpatient Medical Director for the Cancer and Blood Disorders Center.
Dr. Navin Pintos has a longstanding interest in developing more targeted, less toxic therapies for children and young adults with cancer. He completed his fellowship and laboratory training at the University Chicago. Dr. Pinto is board certified in General Pediatrics, Pediatric Hematology/Oncology and Clinical Pharmacology. He has worked extensively in the field of cancer pharmacogenomics: using a patients genetic code to predict sensitivity to a given treatment regimen.
In addition to his work in pharmacogenomics, Dr. Pinto is interested in bringing novel treatments to patients with relapsed or refractory solid tumors. He is involved in several Phase I trials at Seattle Childrens Hospital and works with collaborative groups locally, nationally and internationally to bring new treatments to the clinic. He is an active member of the Childrens Oncology Group (COG), the New Approaches to Neuroblastoma Therapy (NANT) and the Genomic Assessment Informing Novel Therapeutics (GAIN) consortia.
Dr. Pinto is dedicated to offering hope to children with complex solid malignancies such as neuroblastoma and sarcoma by providing access to the most promising and innovative therapies.
Saint Louis University School of Medicine, St Louis
Pediatrics, University of Chicago, Chicago
Pediatric Hematology-Oncology, University of Chicago, Chicago
MB.8.501 - Hematology-Oncology
4800 Sand Point Way NE
Type the first or last name you are searching for or select a specialty.